Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeDropped

Termination of the Tiroblock sales agreement with 物産アニマルヘルス株式会社

First written in FY2027-H1. 1 of 1 entries say "Dropped", first in FY2027-H1. Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Termination of the Tiro Block sales agreement with 物産アニマルヘルスA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1DroppedAnnual report

    「あすかアニマルヘルス株式会社 物産アニマルヘルス株式会社 Japan Veterinary pharmaceutical Tiroblock tablets License of sales rights Five years from November 2019, followed by automatic one-year renewals (agreement ended on 22 June 2026)」

    The company disclosed that the sales rights license agreement for Tiroblock tablets ended on 22 June 2026.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Termination of the Tiroblock sales agreement with 物産アニマルヘルス株式会社 | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) | Komori